Compare CBZ & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CBZ | ANIP |
|---|---|---|
| Founded | 1987 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 1.9B |
| IPO Year | 1996 | 1999 |
| Metric | CBZ | ANIP |
|---|---|---|
| Price | $54.50 | $77.74 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 5 |
| Target Price | $41.33 | ★ $110.00 |
| AVG Volume (30 Days) | ★ 1.8M | 256.0K |
| Earning Date | 04-29-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 134.62 | ★ 419.23 |
| EPS | ★ 2.83 | 2.32 |
| Revenue | ★ $922,003,000.00 | $206,547,000.00 |
| Revenue This Year | $3.92 | $21.01 |
| Revenue Next Year | $4.12 | $17.59 |
| P/E Ratio | ★ $19.25 | $64.55 |
| Revenue Growth | ★ 7.79 | 2.47 |
| 52 Week Low | $24.29 | $70.15 |
| 52 Week High | $67.24 | $99.50 |
| Indicator | CBZ | ANIP |
|---|---|---|
| Relative Strength Index (RSI) | 81.19 | 56.20 |
| Support Level | $50.29 | $76.87 |
| Resistance Level | $55.39 | $83.45 |
| Average True Range (ATR) | 1.02 | 2.18 |
| MACD | 0.80 | 0.24 |
| Stochastic Oscillator | 93.34 | 91.45 |
CBIZ Inc through its subsidiaries provides professional services advisors to middle-market businesses and organizations nationwide. Its business units have been aggregated into three practice groups: Financial Services, Benefits and Insurance Services, and National Practices. The company provides its services to various industries such as Banking & Financial Services, Commercial Real Estate, Construction, Health Care Manufacturing & Distribution NFP & Education, Private Client Services, Professional Services, Public Sector, and Technology & Life Sciences. It derives the maximum of its revenues from the Financial Services segment and geographically from the United States.
ANI Pharmaceuticals Inc is a diversified biopharmaceutical company. It is focused on developing, manufacturing, and commercializing therapeutics through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology, and pulmonology; and through its Generics and Brands businesses. The firm's product portfolio comprises Purified Cortrophin Gel, ILUVIEN, and YUTIQ (fluocinolone acetonide intravitreal implant), among others. Additionally, its Generics portfolio includes several products with a wide variety of indications. The company has two operating segments: Rare Disease and Brands, which derive maximum revenue, and Generics and Other. Geographically, it generates maximum revenue from the United States, followed by other markets.